As a definite immunoprofile of this
tumor is missing, the histopathologic diagnosis of
intrahepatic cholangiocarcinoma is difficult. The aim of this study was to explore E- and
N-cadherin expressions in intrahepatic bile duct
tumors, and to determine their potential interest in differential diagnosis. Normal liver tissue, 5
cirrhosis with ductular reaction, 5
focal nodular hyperplasia, 5 bile duct
hamartomas, 5
bile duct adenomas, and 45
intrahepatic cholangiocarcinomas from Caucasian patients were studied. Tissue-microarrays including 20 esophageal, 86 gastric, 8 small bowel, 64 colonic, 18 pancreatic, 6 gallbladder, and 7 extrahepatic biliary tract
adenocarcinomas, 22
hepatocellular carcinomas, and normal tissues were constructed. Immunohistochemistry was performed using
E-cadherin,
N-cadherin,
NCAM, Hep Par1, and cytokeratins 7, 19 and 20. Immunoblot analysis of frozen liver tissues was performed to control the specificity of E- and
N-cadherin antibodies used. In normal liver, epithelial cells of intrahepatic bile ducts, whatever their caliber, as well as hepatocytes, coexpressed E- and
N-cadherins at their plasma membranes. In
cirrhosis, ductular reactions completely expressed E- and
N-cadherins. All the benign lesions and 30 of the 45
intrahepatic cholangiocarcinomas (23/29 peripheral and 7/16 hilar) also expressed
N-cadherin.
E-cadherin was detected in all the lesions. The expression of
N-cadherin at the plasma membrane of
tumor cells was significantly more frequent in peripheral than in hilar
intrahepatic cholangiocarcinomas (P=0.003). Among noncholangiocarcinomas, only 1% gastric and 66% gallbladder
adenocarcinomas and all the
hepatocellular carcinomas expressed
N-cadherin at the membrane of
tumor cells. Finally, for the diagnosis of
intrahepatic cholangiocarcinomas, the specificity value of membranous expression of
N-cadherin was 88%, whereas that of the combination
cytokeratin 7/membranous
N-cadherin was 98%. In the gastrointestinal and liver tract, membranous
N-cadherin is restricted to the hepatocytes and intrahepatic biliary cells. In combination with
cytokeratin 7 and Hep Par1,
N-cadherin is a reliable tool for the histopathological diagnosis of primary hepatic
tumors.